High Effectiveness of the Bivalent Human Papillomavirus (HPV) Vaccine Against Incident and Persistent HPV Infections up to 6 Years After Vaccination in Young Dutch Women
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High Effectiveness of the Bivalent Human Papillomavirus (HPV) Vaccine Against Incident and Persistent HPV Infections up to 6 Years After Vaccination in Young Dutch Women
Authors
Keywords
-
Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 217, Issue 10, Pages 1579-1589
Publisher
Oxford University Press (OUP)
Online
2018-02-02
DOI
10.1093/infdis/jiy067
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Worldwide burden of cancer attributable to HPV by site, country and HPV type
- (2017) Catherine de Martel et al. INTERNATIONAL JOURNAL OF CANCER
- The impact of bivalent HPV vaccine on cervical intraepithelial neoplasia by deprivation in Scotland: reducing the gap
- (2017) Ross L Cameron et al. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
- No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors
- (2017) Petra J. Woestenberg et al. JOURNAL OF INFECTION
- Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors
- (2017) Petra J Woestenberg et al. JOURNAL OF INFECTIOUS DISEASES
- Evaluation of Type Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two Randomized Trials
- (2017) Joseph E. Tota et al. JNCI-Journal of the National Cancer Institute
- Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study
- (2017) Kimberley Kavanagh et al. LANCET INFECTIOUS DISEASES
- Evaluation of Type Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two Randomized Trials
- (2017) Joseph E. Tota et al. JNCI-Journal of the National Cancer Institute
- Præventis, the immunisation register of the Netherlands: a tool to evaluate the National Immunisation Programme
- (2017) A van Lier et al. Eurosurveillance
- Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis
- (2016) Laia Bruni et al. Lancet Global Health
- Efficacy of Human Papillomavirus 16 and 18 (HPV-16/18) AS04-Adjuvanted Vaccine against Cervical Infection and Precancer in Young Women: Final Event-Driven Analysis of the Randomized, Double-Blind PATRICIA Trial
- (2015) Dan Apter et al. Clinical and Vaccine Immunology
- Effectiveness of human papillomavirus vaccine against incident and persistent infections among young girls: Results from a longitudinal Dutch cohort study
- (2015) Madelief Mollers et al. VACCINE
- Equity in human papilloma virus vaccination uptake?: sexual behaviour, knowledge and demographics in a cross-sectional study in (un)vaccinated girls in the Netherlands
- (2014) Madelief Mollers et al. BMC PUBLIC HEALTH
- Declining Genital Warts in Young Women in England Associated With HPV 16/18 Vaccination: An Ecological Study
- (2013) Rebecca Howell-Jones et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy of the HPV-16/18 AS04-Adjuvanted Vaccine Against Low-Risk HPV Types (PATRICIA Randomized Trial): An Unexpected Observation
- (2013) A. Szarewski et al. JOURNAL OF INFECTIOUS DISEASES
- Clinical trials of human papillomavirus vaccines and beyond
- (2013) Matti Lehtinen et al. Nature Reviews Clinical Oncology
- Prevalence of genital HPV infections and HPV serology in adolescent girls, prior to vaccination
- (2012) M. Mollers et al. Cancer Epidemiology
- Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis
- (2012) Talía Malagón et al. LANCET INFECTIOUS DISEASES
- Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
- (2010) Silvia de Sanjose et al. LANCET ONCOLOGY
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
- (2009) J Paavonen et al. LANCET
- Determinants for HPV vaccine uptake in the Netherlands: A multilevel study
- (2009) Marc Rondy et al. VACCINE
- Comparison of GP5+/6+-PCR and SPF10-Line Blot Assays for Detection of High-Risk Human Papillomavirus in Samples from Women with Normal Cytology Results Who Develop Grade 3 Cervical Intraepithelial Neoplasia
- (2008) A. T. Hesselink et al. JOURNAL OF CLINICAL MICROBIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started